Literature DB >> 29861151

Infection prevention staffing and resources in U.S. acute care hospitals: Results from the APIC MegaSurvey.

Monika Pogorzelska-Maziarz1, Heather Gilmartin2, Sara Reese3.   

Abstract

BACKGROUND: Given the changing nature of infection prevention and control (IPC), appropriate infection preventionist (IP) staffing needs to be established. In this study, we aimed to describe current IP staffing levels and IPC department resources in U.S. acute care hospitals.
METHODS: These data came from the 2015 MegaSurvey conducted by the Association of Professionals in Infection Prevention and Epidemiology. Descriptive statistics and bivariate analyses were conducted to examine differences in respondent, facility, and department characteristics by facility size (average inpatient census ≤100 vs >100).
RESULTS: Data from 1623 respondents were included. Most (72%) had single-site responsibilities and dedicated 76%-100% of their job to IPC (68%). The overall median IP staffing was 1.25 IPs per 100 inpatient census (interquartile range = 1.81). Almost half (46%) represented facilities with daily inpatient census ≤100; the average number of IPs in these facilities was 1.1 (standard deviation = 0.7). The reported number of IPs increased steadily with higher patient census. Significant differences were observed in IP staffing, responsibilities, and support to the IPC department between smaller and larger hospitals.
CONCLUSIONS: This study represents the current snapshot of IP staffing and IPC resources in acute care hospitals. Findings indicate important differences between large and small facilities in staffing and IPC resources. The field of infection prevention would benefit from a comprehensive assessment of IPC department staffing and resource needs.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.

Entities:  

Keywords:  Acute care hospitals; Infection prevention; Infection preventionists; Staffing

Mesh:

Year:  2018        PMID: 29861151     DOI: 10.1016/j.ajic.2018.04.202

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Recruitment and hiring practices in United States infection prevention and control departments: Results of a national survey.

Authors:  Heather Gilmartin; Sara M Reese; Sarah Smathers
Journal:  Am J Infect Control       Date:  2020-07-21       Impact factor: 2.918

2.  Recommendations for change in infection prevention programs and practice.

Authors:  Robert Garcia; Sue Barnes; Roy Boukidjian; Linda Kaye Goss; Maureen Spencer; Edward J Septimus; Marc-Oliver Wright; Shannon Munro; Sara M Reese; Mohamad G Fakih; Charles E Edmiston; Martin Levesque
Journal:  Am J Infect Control       Date:  2022-05-04       Impact factor: 4.303

3.  Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.

Authors:  Li-Hsiang Su; I-Ling Chen; Ya-Fen Tang; Jen-Sin Lee; Jien-Wei Liu
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

4.  Challenges of infection control capacity in the Middle Eastern countries; time to be actively involved.

Authors:  Majid M Alshamrani; Aiman El-Saed; Fayssal M Farahat
Journal:  J Infect Public Health       Date:  2022-03-23       Impact factor: 3.718

5.  Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator).

Authors:  Caitlin M Dugdale; David M Rubins; Hang Lee; Suzanne M McCluskey; Edward T Ryan; Camille N Kotton; Rocio M Hurtado; Andrea L Ciaranello; Miriam B Barshak; Dustin S McEvoy; Sandra B Nelson; Nesli Basgoz; Jacob E Lazarus; Louise C Ivers; Jennifer L Reedy; Kristen M Hysell; Jacob E Lemieux; Howard M Heller; Sayon Dutta; John S Albin; Tyler S Brown; Amy L Miller; Stephen B Calderwood; Rochelle P Walensky; Kimon C Zachary; David C Hooper; Emily P Hyle; Erica S Shenoy
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.